What We’ve Done, Where We’re Going: The History & Future of HIV/AIDS and its Sociology Sam Friedman.

Slides:



Advertisements
Similar presentations
HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS.
Advertisements

HIV, Infectious Diseases, and Drug Use in Networks and Communities I would like to acknowledge: NIDA projects: R01 DA13128 (Networks, norms & HIV risk.
1 Global AIDS Epidemic The first AIDS case was diagnosed in years later, 20 million people are dead and 37.8 million people (range: 34.6–42.3 million)
Networks and interventions Acknowledgements USA National Institute on Drug Abuse Social Factors and HIV Risk (R01 DA06723) Drug use and HIV risk among.
Risk Networks, Groups Sex and Other Risk "Nodes," and HIV Transmission: Mixing Patterns and the Limitations of Current HIV and Drug Use Interventions.
CDC-NIMH Conference Closing Meditations Thomas J. Coates PhD Professor of Medicine Director, AIDS Research Institute University of California San Francisco.
Theory and practice of harm reduction Samuel R. Friedman National Development and Research Institutes, Inc. New York, NY.
Brief Interventions for HIV+ Persons Thomas L. Patterson Shirley J. Semple University of California, San Diego Research supported by NIMH RO1MH61146 &
HIV/AIDS AMONG LATINOS IN NEW JERSEY presented by: Gloria M. Rodriguez, DSW Assistant Commissioner Division of AIDS Prevention and Control presented at.
HIV/AIDS Prevalence & Mortality Report, 2010 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
Lessons learned from Nairobi, and experiences from Serbia Mr.sci.prim.dr Dragan Ilić epidemiologist Република Србија МИНИСТАРСТВО ЗДРАВЉА 1.
Topic 2 The prevalence of HIV/AIDS and its potential impact on individuals, communities and countries Slide 2.1.
The intermeshed sexual networks of drug users, MSM, WSW and other community members Samuel R Friedman* Melissa Bolyard Carey Maslow Pedro Mateu-Gelabert.
HIV/AIDS Prevalence & Mortality Report, 2001 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
Ivan Cruickshank Caribbean Vulnerable Communities Coalition.
HIV Infection Among Those with an Injection Drug Use*- Associated Risk, Florida, 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
HIV/AIDS Chapter 21 Human Immunodeficiency Virus (HIV) Acquired immune Deficiency Syndrome (AIDS) (Pg 496)
AIDS Epidemic and Control in China Zeng Yi Chinese Foundation for Prevention of STD and AIDS.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
“A VISION OF HOPE” EXPERIENCE OF SENEGAL IN THE FIGHT AGAINST AIDS AND REDUCING WOMEN’S VULNERABILITY Dr Khoudia Sow, CRCF, UMI 233 Dakar Sénégal.
Divergent Patterns of Amphetamine Use in the City and Rural Areas in Northwest Poland Sobeyko J (1), Leszczyszyn-Pynka M (2), Parczewski M (2), Burris.
Breaking Down Barriers: Access to HIV Testing and Treatment for San Franciscans Affected by Mental Health and Substance Use Prepared for: HIV Prevention.
Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.
Chapter 1: An Overview of the HIV/AIDS Epidemic Module 1, Chapter 1.
HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.
Milwaukee Partnership to Respond to 2009 EPI AID Study in Milwaukee Brenda Coley Diverse and Resilient, Inc.
HIV and AIDS Data Hub for Asia-Pacific 11 HIV and AIDS Data Hub for Asia-Pacific Review in slides Afghanistan.
Unifying science, education and service to transform lives Module 11 Clinical Issues with Youth A Provider’s Introduction to Substance Abuse for Lesbian,
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
ABSTRACT Introduction: HIV infection is growing relatively fast among seniors. Among the clinical implications are that older patients have less ability.
The HIV virus. The overwhelming majority of people with HIV live in low- and middle-income countries. Sub- Saharan Africa accounts for two-thirds.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Key Affected Populations.
HIV/AIDS VACCINE AWARENESS Vaccine 101 Jeremiah Brewer Health and Training Educator African – Americans Reach and Teach Health Ministry.
1 OPA/OFP HIV Prevention Project Annual Technical Support Conference Six Years of HIV Supplemental Grants – A National Perspective Susan B. Moskosky Director,
2008 Minnesota HIV/AIDS Surveillance Report - Key Trends Lorraine Teel- Executive Director.
Data Trends: FPAR & HIV Prevention Project OPA/OFP HIV Prevention Project Annual Technical Support Conference June 12, 2007 Presented by Kelly Morrison.
Kevin Fenton, MD, PhD National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention August 5, 2008 Update on the US HIV/AIDS Crisis: Current Trends,
Welcome to Soc 1A! Quick Writing and Attendance Review Syllabus Sociological Perspective and Analysis Homework:  Introduction to Sociology: Chapter 1.
Technological Fix 1. Why is there inequality in access to technology ? a) What is technology and how is developed? b) Global distribution of a range of.
Risk networks, infectious diseases, social norms, risk behaviors and health activism “intravention” Samuel R Friedman* Melissa Bolyard Carey Maslow Pedro.
Partnering to Promote Female-controlled HIV Prevention Methods Matthews J, Becker J, Massey C, Jacobsen J, Patel B Ibis Reproductive Health, International.
Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais,
How Does Trauma contribute to Substance Abuse and HIV Infection Among Ethnic Women Gail E. Wyatt, Ph.D. Professor, UCLA Department of Psychiatry and Biobehavioral.
REPORT – International AIDS Conference Thando Khaile SABCOHA.
1 Where have we failed? Findings of the Commission on AIDS in Asia Tim Brown East-West Center Modes of Transmission in the Philippines Stakeholders’ meeting.
Richard Wolitski, PhD Division of HIV/AIDS Prevention Housing and Health : A CDC Perspective July 21, 2012 AIDS 2012 International Housing Summit World.
Country gallery Maldives. Basic socio-demographic indicators, Total population (thousands)306 Annual population growth rate2.4 Population aged.
Effects of Pharmacy Syringe Access Among Young Heroin Injectors Results IDU needle sharing decreased after the enactment of the pharmacy access law in.
HIV/AIDS Summary of Questions. What is HIV? Human immunodeficiency virus (remember, no official scientific name for viruses) Human immunodeficiency virus.
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
HIV/AIDS in Eastern Europe Setting the Stage for Prevention HIV/AIDS in Eastern Europe Setting the Stage for Prevention Thomas E. Novotny, MD, MPH April.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
Intro to HIV/AIDS for Gifted Hands Volunteers Jennifer Samuels, MPH AIDS Service Center NYC
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Bad Blood? An Investigation of the MSM Ban on Blood Donation Lauren Lacy Abstract In 1983, the Food and Drug Administration (FDA), responding to the AIDS.
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
Abstract #TUPDE202: Collaboration and Cross Training between Health and Correctional Services Leads to More Integrated Services for PHAs in Prison: Poster.
Global Impact of HIV/AIDS Deborah Lewinsohn, M.D. Infectious Diseases, Pediatrics Vaccine and Gene Therapy Institute Oregon Health & Science University.
Claudia L. Moreno, Ph.D., MSW
Dialectical theory and the HIV/AIDS epidemic
Developing Measures of Pathways That May Link Large-scale Social Structural Factors with HIV Epidemiology Enrique R. Pouget, Milagros Sandoval, Yolanda.
Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald
Key Affected Populations
Tearing Down Fences HIV/STD Prevention in Rural America
Key Affected Populations
Review in slides Most-at-risk populations
Presentation transcript:

What We’ve Done, Where We’re Going: The History & Future of HIV/AIDS and its Sociology Sam Friedman

I would like to acknowledge NIDA projects: –R01 DA DA A1 Staying Safe: Long-term IDUs who have avoided HIV & HCV –P30 DA11041 (Center for Drug Use and HIV Research; Sherry Deren PI) –R01 DA13336 (Community Vulnerability and Response to IDU-Related HIV project) –R01 DA13128 (Networks, norms & HIV risk among youth) –R01 DA Social Factors and HIV Risk –R01 DA03574 (Risk Factors for AIDS among Intravenous Drug Users ; DC Des Jarlais, PI) Hundreds of participants in these studies Colleagues and participants who have died of HIV/AIDS and hepatitis C Many collaborators and co-authors

What we have done Early prevention work by sociologists with drug users included Wayne Wiebel’s indigenous leader outreach model; my work on organizing drug users against HIV/AIDS; and San Francisco CHOW. ALL of these have guided a lot of subsequent work in various countries MUCH sociological work has focused on supra-individual levels of analysis and structural interventions (Blankenship; Rhodes)—though I am not sure this was fully represented earlier today. Work on risk networks and how HIV is transmitted. Martina Morris, Alan Neaigus, and I have been deeply involved. Comparative studies of MSAs in the CVAR project; and Ricky Bluthentahl and his colleagues have compared SEP programs, behaviors and infection in a number of California localities.

Other important work has been done by many sociologists in this room and elsewhere. Some of these sociologists work in difficult circumstances without public or professional recognition. This relative lack of recognition is in part due to the overwhelmingly individualistic/medical focus of the AIDS research field.

HIV risk is a conditional probability +, on HAART HIV Negative Unknown, but GC+ and HSV-2+ The probability is socially structured -

Attended Group Sex Party (Pluses) and Had Unsafe Sex at Group Sex Party (Circles) by Gender/Sexuality (MSM=up triangle, WSW=down triangle, other female=circle, other male=square) by Hardest Drug Use Ever (from dark red to light pink: IDU, Crack, NI Heroin or Cocaine; blue=other) by Link Type (sex=yellow line, IDU=red, sex and IDU=blue) Friedman, Samuel R; Bolyard, Melissa; Khan, Maria; Maslow, Carey; Sandoval, Milagros; Mateu-Gelabert, Pedro; Krauss, Beatrice; Aral, Sevgi O. (2008). Group Sex Events and HIV/STI Risk in an Urban Network. J Acq Immun Syn.49(4):

Diagram published in: Friedman, Samuel R; Rossi, Diana; Braine, Naomi. (2009). Theorizing “Big Events” as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks. International Journal on Drug Policy 20: Sex and drug networks and behaviors may include Quasi-anonymous risk nodes like group sex events or shooting galleries Big Events research: Why do some transitions lead to HIV epidemics and others not?

Responses to what sociologists have done Policy remains relentlessly behaviorally and medically focused. In the first 6 of the NIDA NADR outreach projects, supra- individual projects (Wiebel, San Francisco CHOWs, my organizing) led the way. But the behavioralists won the internal battles in NIDA, and by the second and third waves of grants later in the year, the behavioral-counseling individual randomized control model won out. Similar patterns have happened at NIMH and CDC. And increasingly the focus in Washington, Atlanta and internationally is on “bio-behavioral intervention” like testing, microbicides, circumcision and vaccines—with social and even behavioral sciences useful mainly as adjuncts to them.

What is to be done? Thoughts on research topics (1) Studies of dialectics of policy formation Comparative longitudinal studies of epidemics and of responses: –a Community Vulnerability and Response study of MSM epidemics in US cities –Comparative studies of Big Events Most research on gender and HIV has been too social psychological, dyadic, behavioral or interpretive. Too little has looked at issues like how the strength of feminist movements and/or the relative exploitation of men and women affect local or national epidemics and responses. How do community structures, processes, policies, and human agency affect the prevalence of kinds of “risk environments” (Tim Rhodes) like group sex and injection events, what people do in them, and how participants can protect themselves.

What is to be done? Thoughts on research topics (2) Studies of socially-created categories of high-risk people or events that are missed by surveillance categories defined by behavioral epidemiology: –Non-injecting drug users are likely a very large percent of “heterosexual transmission cases” –Many of the rest are women who have sex with women and also with MSM or male IDUs or NIDUs. Race, racism and HIV: “Disparities research” has not taken advantage of the rich knowledge developed by sociology. See the next slide from Friedman, Cooper & Osborne (2009, AJPH) as but one example of how sociology might broaden research on the epidemic among African Americans.

Relationships among racialized social structures and processes and HIV-relevant cultural themes, subcultures, networks and behaviors among African Americans Friedman, S.R.; Cooper, H.L.F.; Osborne, A. (2009). Structural and social contexts of HIV risk among African-Americans. American Journal of Public Health. 99: , /AJPH

What kind of sociology? Material reality is obviously important. So are subjective ideas and social-physical practice. Marxism seems well-suited for such analyses and action Looming issues it points to now include the politics of hard times: –Making do in spite of cutbacks –Fighting back successfully against cutbacks –“Divide & Rule” strategies by capitalists, their media and the State—and their implications for increasing stigmatization and repression, and revivals of racism, sexism and attacks on workers. –Social movements of hard times—and new forms and organizations of struggle –And how and when drug users, gay men, women, and people in Africa, East Europe, Asia and Latin America can combine their struggles with these upcoming social movements

Final thoughts Why has sociology been so weak in the politics of HIV/AIDS? I would start with the general failure of the Left in the 80s and since, which was based on and contributed to weak movements This was reflected in the individualist focus of “scientific thought” and of most HIV prevention and even care. In sociology, this led to a focus on risk behaviors, on forms of symbolic interactionism disassociated from its “natural” relation to Marxism, and on post-modernist and cultural turns. These turned sociology away from a dialectical focus on the interaction of social processes, the virus, and the epidemic--and weakened community responses. This may have been less true for IDU studies and action, but has been strong there too. My work has been cited by some as a model. Please be aware that it is based on a Marxist dialectics of the real.